Cardiology (all articles)
Stroke–heart syndrome: recent advances and challenges.
7 Sep, 2022 | 12:35h | UTCStroke–Heart Syndrome: Recent Advances and Challenges – Journal of the American Heart Association
Commentary on Twitter
Proud to share our updated review about the stroke-heart syndrome. Read more about recent advances on how brain ischemia can trigger cardiac events. https://t.co/ywJs2JbZht Many thanks to @SposatoL, @JohannesBacks and @Dr_No_Charite for your contribution! #brainheart #strokeheart pic.twitter.com/3IV9LU7fJN
— Jan Scheitz 🧠⚡️❤️ (@Jan_FriSch) September 3, 2022
Under a Creative Commons Attribution‐Non Commercial‐No Derivs License
Patent ductus arteriosus: a contemporary perspective for the pediatric and adult cardiac care provider.
7 Sep, 2022 | 12:34h | UTC
Predictive role of atrial fibrillation in cognitive decline: a systematic review and meta-analysis of 2.8 million individuals.
7 Sep, 2022 | 12:30h | UTC
Commentary on Twitter (thread – click for more)
AF associated with ⬆️ risk of cognitive impairment 👉
📌 HR 1.39 general 👫
📌 HR 2.70 post-stroke 👫@natale_md @TJaredBunch @Dr_Santangeli @JonPicciniSr @DrMarthaGulati @rafavidalperez @DhirajGuptaBHRS @SABOURETCardio @iamritu @Hragy @mmamas1973 @SeguraCardio @cpgale3 #afib pic.twitter.com/dZxkd7G1wc— Raviele Antonio (@drraviele) January 21, 2022
Under a https://creativecommons.org/licenses/by/4.0/ license
Review | Cardiovascular complications of immune checkpoint inhibitors for cancer.
6 Sep, 2022 | 14:20h | UTCCardiovascular complications of immune checkpoint inhibitors for cancer – European Heart Journal
Related:
Cardiotoxicity of immune checkpoint inhibitors – ESMO Open
Cardiotoxicity from immune checkpoint inhibitors – IJC Heart & Vasculature
Commentary on Twitter
Must read state-of-the-art review: Cardiovascular complications of immune checkpoint inhibitors for cancer https://t.co/0lr7g6s8g0
#EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/jORaTzP7GD— European Society of Cardiology Journals (@ESC_Journals) September 5, 2022
Review | Airway management during cardiopulmonary resuscitation.
6 Sep, 2022 | 14:17h | UTCAirway Management During Cardiopulmonary Resuscitation – Current Anesthesiology Reports
Consensus Statement | Preoperative management of cardiovascular medications.
5 Sep, 2022 | 14:42h | UTCRelated:
Preoperative Management of Medications for Neurologic Diseases – Mayo Clinic Proceedings
Preoperative Management of Surgical Patients Using Dietary Supplements – Mayo Clinic Proceedings
Perioperative Evaluation and Management of Endocrine Disorders – Mayo Clinic Proceedings
Preoperative Cardiac Risk Assessment – Mayo Clinic Proceedings
Preoperative Evaluation Before Noncardiac Surgery – Mayo Clinic Proceedings
Perioperative Cardiac Risk Reduction in Noncardiac Surgery – Mayo Clinic Proceedings
Perioperative Venous Thromboembolism Prophylaxis – Mayo Clinic Proceedings
Cohort Study | Habitual alcohol intake and risk of atrial fibrillation in young adults.
5 Sep, 2022 | 14:33h | UTCHabitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea – JAMA Network Open
Invited Commentary: Self-reported Alcohol Consumption and Risk of Atrial Fibrillation – JAMA Network Open
Review | Right ventricular function across the spectrum of health and disease.
5 Sep, 2022 | 14:30h | UTCRight ventricular function across the spectrum of health and disease – Heart
Commentary on Twitter
Right ventricular function across the spectrum
of health and disease https://t.co/3i9iiddsyV #echofirst #Cardiotwitter #CardioEd #MedEd #CardioTwitteros pic.twitter.com/Q219nvnu6v— Sergio Moreno M (@Serginho1409) July 11, 2022
Under a http://creativecommons.org/licenses/by-nc/4.0/ license
2022 ACC Expert Consensus | Role of nonstatin therapies for LDL-cholesterol lowering and managing cardiovascular disease risk.
2 Sep, 2022 | 13:17h | UTCNews Release: ACC Issues Guidance to Address New Nonstatin Therapies – American College of Cardiology
Commentary: New on the Scene Nonstatin Drugs: Experts Provide Guidance – TCTMD
Commentary on Twitter
📢 ACC releases Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of ASCVD Risk
Read more: https://t.co/WDOSPgQ1bx #ACCClinicalDoc pic.twitter.com/nt8S2pdBgD
— American College of Cardiology (@ACCinTouch) August 25, 2022
RCT | Fractional flow reserve or intravascular ultrasonography to guide percutaneous coronary intervention.
2 Sep, 2022 | 13:15h | UTCFractional Flow Reserve or Intravascular Ultrasonography to Guide PCI – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Fractional Flow Reserve Noninferior to IVUS for Guiding PCI – HealthDay
JCS 2022 Guideline on management and re-interventional therapy in patients with congenital heart disease in the long-term after the initial repair.
2 Sep, 2022 | 13:10h | UTC
AHA Scientific Statement | Management of infective endocarditis in people who inject drugs.
1 Sep, 2022 | 12:00h | UTCNews Release: Addiction management is key to treating heart infection in people who inject drugs – American Heart Association
Top Things to Know: Infective Endocarditis in People Who Inject Drugs – American Heart Association
Video: Management of Infective Endocarditis in People who Inject Drugs – American Heart Association
Commentaries:
AHA Addresses Infective Endocarditis in Injection Drug Users – HealthDay
Related: Management of Infective Endocarditis in People Who Inject Drugs – American College of Cardiology (the original article is paywalled but has an informative infographic)
Cohort Study | Women have a lower incidence of ventricular fibrillation compared to men after an acute myocardial infarction.
1 Sep, 2022 | 11:49h | UTC
Study shows dentists should give antibiotics to high-risk patients to help prevent infectious endocarditis.
1 Sep, 2022 | 11:43h | UTCOriginal Study: Antibiotic Prophylaxis Against Infective Endocarditis Before Invasive Dental Procedures – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentary: UK dentists should give antibiotics to patients at risk of heart infection – study – The Guardian
Review/Perspective | European hypertension guideline downgrading of beta-blockers is not justified.
31 Aug, 2022 | 11:51h | UTC
Meta-analysis of cohort studies | Vegetarian and vegan diets and the risk of cardiovascular disease, ischemic heart disease and stroke.
31 Aug, 2022 | 11:42h | UTC
Long-term results of a RCT | Self-expanding transcatheter vs. surgical aortic valve replacement in intermediate-risk patients.
31 Aug, 2022 | 11:38h | UTCSelf-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)
Original article: Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients – New England Journal of Medicine
Commentary on Twitter
Among intermediate-risk patients with symptomatic severe aortic stenosis, clinical outcomes at 5 years were similar and bioprosthetic valve performance remained stable after transcatheter aortic valve replacement and surgery. https://t.co/rVcVoSMpG4 #OrigResearch
— JAMA Cardiology (@JAMACardio) August 26, 2022
M-A | Efficacy of telemedicine for the management of cardiovascular disease.
31 Aug, 2022 | 11:35h | UTC
Cohort Study | Electrocardiographic findings associated with early clinical deterioration in acute pulmonary embolism.
31 Aug, 2022 | 11:30h | UTC
#ESCCongress – M-A | Radial access for coronary interventions confers lower mortality than femoral access.
30 Aug, 2022 | 12:17h | UTCNews Release: Radial access for coronary interventions confers lower mortality than femoral access – European Society of Cardiology
Original Study: Impact on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: a Meta-analysis of Individual Patient Data from Seven Multicenter Randomized Clinical Trials – Circulation (free for a limited period)
Commentary: Less Death, Major Bleeding With Transradial Access: Meta-analysis – TCTMD
Commentary on Twitter
#OriginalResearch SimPub #ESCCongress: In a individual-level meta-analysis of 21,600 patients undergoing coronary angiography, radial approach was associated with ⬇️ all-cause mortality (1.5 vs 2.1%) and ⬇️… @GargiuloG83 @vlgmrc @DanieleGiacoppo @SVRaoMD https://t.co/aOJ7ZgaJmK pic.twitter.com/gbWzUNTQck
— Circulation (@CircAHA) August 29, 2022
#ESCCongress | Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomized, double-blind trials.
30 Aug, 2022 | 12:16h | UTCNews Release: Cardiovascular protection from statins greatly outweighs the risk of muscle symptoms – European Society of Cardiology
Commentary: Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration – TCTMD
#ESCCongress – Meta-analysis of randomized trials | Angiotensin receptor blockers and Beta-blockers in Marfan syndrome: an individual patient data meta-analysis of randomized trials.
30 Aug, 2022 | 12:15h | UTCNews Release: Drug combination may delay need for surgery in patients with Marfan syndrome – TCTMD
Commentary: ARBs Halve Rate of Aortic Root Enlargement in Marfan: Meta-analysis – TCTMD
#ESCCongress – M-A | Patients with heart failure benefit from dapagliflozin regardless of ejection fraction.
30 Aug, 2022 | 12:14h | UTCNews Release: Patients with heart failure benefit from dapagliflozin regardless of ejection fraction – European Society of Cardiology
Related:
Consensus Statement | Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis.
30 Aug, 2022 | 12:10h | UTC
Commentary on Twitter
Lipoprotein(a) in atherosclerotic CV and aortic stenosis – a European Atherosclerosis Society consensus statement https://t.co/Bzzpd3Bx8M
#EHJ #ESCCongress #ESCYoung @escardio @ehj_ed @rladeiraslopes pic.twitter.com/ZcqaPe581K
— European Society of Cardiology Journals (@ESC_Journals) August 29, 2022
#ESCCongress | Study shows long-term Evolocumab appears to be safe in patients with established atherosclerotic cardiovascular disease.
30 Aug, 2022 | 12:12h | UTCNews Release: Long-term evolocumab therapy leads to further reductions in cardiovascular events – European Society of Cardiology
Original Article: Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease – New England Journal of Medicine
Commentary on Twitter
#OriginalResearch SimPub #ESCCongress: In this open-label extension of #FOURIER RCT, long-term evolocumab therapy for >8 yrs was associated w/ persistently low rates and greater reduction in MACE compared w/ delayed treatment initiation among patients w… https://t.co/9g97s4MZSt pic.twitter.com/y5uN53gdKo
— Circulation (@CircAHA) August 29, 2022